M&T Bank Corp Acquires 367 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

M&T Bank Corp increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 29,784 shares of the real estate investment trust’s stock after purchasing an additional 367 shares during the quarter. M&T Bank Corp’s holdings in Omega Healthcare Investors were worth $1,212,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of OHI. State Street Corp increased its holdings in shares of Omega Healthcare Investors by 0.9% in the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock worth $502,228,000 after buying an additional 114,085 shares during the last quarter. Assetmark Inc. grew its holdings in Omega Healthcare Investors by 1.7% in the 3rd quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust’s stock worth $48,492,000 after acquiring an additional 19,542 shares during the last quarter. BNP Paribas Financial Markets raised its position in Omega Healthcare Investors by 120.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust’s stock valued at $9,212,000 after purchasing an additional 123,836 shares during the last quarter. Daiwa Securities Group Inc. raised its holdings in shares of Omega Healthcare Investors by 317.7% during the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Finally, Caxton Associates LP purchased a new stake in shares of Omega Healthcare Investors in the 2nd quarter worth about $1,652,000. 65.25% of the stock is currently owned by institutional investors.

Insider Activity

In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at approximately $7,357,824.44. This represents a 10.96 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on OHI. Royal Bank of Canada upped their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. BMO Capital Markets raised shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price for the company in a research report on Monday, December 9th. Scotiabank upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Finally, Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective for the company. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $40.18.

Omega Healthcare Investors Price Performance

OHI stock opened at $39.21 on Monday. The company’s fifty day moving average price is $40.38 and its 200-day moving average price is $37.97. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $44.42. The company has a market capitalization of $10.58 billion, a PE ratio of 28.83, a price-to-earnings-growth ratio of 1.21 and a beta of 0.98. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.83%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s payout ratio is presently 197.06%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.